Clinical Trials on Myotonic Dystrophy, Type 1 (DM1)

Total 4345 results

Jaeb Center for Health Research
Juvenile Diabetes Research Foundation; University of Minnesota

Active, not recruiting

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEx)

Type1 Diabetes

United States
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation; University of Minnesota; Medtronic; DexCom... and other collaborators

Completed

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)

Type1 Diabetes

United States
University of Valencia

Active, not recruiting

Protocol for Self-Compassion Intervention for Teens With Diabetes Type 1 and Their Caregivers (SWEET)

Diabetes type1

Spain
Immunomolecular Therapeutics, Inc.
WCCT Global

Completed

Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes

Type1 Diabetes

United States
University Hospital, Lille

Unknown

Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children (DIAB-HELP)

Diabetes type1

France
National Institute of Diabetes and Digestive and...

Withdrawn

Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes (TN-23)

Type1 Diabetes Mellitus
Insulet Corporation

Completed

Insulet Artificial Pancreas Free-Living IDE3

Type1 Diabetes Mellitus

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Cholesterol Lowering and Residual Risk in Diabetes, Type 1 (CHORD1)

Type 1 Diabetes

United States
University of Campania "Luigi Vanvitelli"

Recruiting

Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients (METRO)

Type 1 Diabetes Mellitus

Italy
Radboud University Medical Center

Active, not recruiting

Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D (Honeymoon)

Type 1 Diabetes Mellitus

Netherlands
Centre Hospitalier Universitaire Dijon

Completed

Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients (ApoC1)

diabète de Type 1

France
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust; Nottingham University... and other collaborators

Completed

FASter Insulin in Closed-loop Technology in Children (FAST-Kids)

Type 1 Diabetes Mellitus

United Kingdom
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...

Completed

Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Imperial College London
DexCom, Inc.

Unknown

Clinical Assessment of a Novel Advanced Bolus Calculator for Type 1 Diabetes 5 (ABC4D5)

Type 1 Diabetes Mellitus

United Kingdom
Institut de Recherches Cliniques de Montreal

Completed

Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia

Type 1 Diabetes Mellitus

Canada
Boston Children's Hospital

Completed

Group Education Curriculum for Older Teens With Type 1 Diabetes (SMART T1D)

Type 1 Diabetes Mellitus

United States
AstraZeneca

Completed

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Type 1 Diabetes Mellitus

Japan
Vanderbilt University Medical Center

Completed

Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D

Type 1 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2)

Type 1 Diabetes Mellitus

United States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
AstraZeneca

Completed

The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Type 1 Diabetes Mellitus

Japan
Biocon Limited

Terminated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Type 1 Diabetes Mellitus

India
Joslin Diabetes Center
Novo Nordisk A/S

Terminated

Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

Type 1 Diabetes Mellitus

United States
Assuta Hospital Systems
Maccabi Healthcare Services, Israel

Completed

Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump

Type 1 Diabetes Mellitus

Israel
University of Padova
Azienda Ospedaliera di Padova

Completed

Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes (Basal21)

Type 1 Diabetes Mellitus

Italy
Sansum Diabetes Research Institute
University of Virginia; University of California, Santa Barbara

Completed

Outpatient Control-to-Range: System and Monitoring Testing

Type 1 Diabetes Mellitus

United States
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Artificial Pancreas Control System in an Outpatient Setting

Type 1 Diabetes Mellitus

United States
Kaplan Medical Center

Unknown

Best Timing of Insulin Bolus Before Meals of Different Contents

Type 1 Diabetes Mellitus

Israel
Sanofi

Completed

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes (PRESCHOOL)

Type 1 Diabetes Mellitus

United States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
S-Evans Biosciences Co., Ltd.
Wenzhou Medical University; Zhejiang University; Zhenjiang First People's Hospital

Unknown

Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

Type 1 Diabetes Mellitus

China
University Hospital, Geneva
Swiss National Science Foundation

Completed

Exercise Training Intervention in Children With Type 1 Diabetes (Diabex)

Type 1 Diabetes Mellitus

Switzerland
University of Saskatchewan
The Hospital for Sick Children; University of Calgary; Children's Hospital of...

Recruiting

Canadian Bone Strength Development Study (CanBSDS)

Type-1 Diabetes

Canada
Centre Hospitalier Universitaire Dijon

Completed

Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function (Holter Gly)

Type-1 Diabetes

France
Eddii, Inc.

Completed

Safety and Feasibility Study of the Eddii Mobile Application

Type-1 Diabetes

United States
University of California, San Diego
Juvenile Diabetes Research Foundation

Completed

Dapagliflozin Effects on Hypoglycemia

Type1 Diabetes Mellitus

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 (iDCL)

Type1 Diabetes Mellitus

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients (T1DM AP)

Type1 Diabetes Mellitus

United States
Radboud University Medical Center
HypoResolve

Unknown

Current State of Impaired Awareness of Hypoglycaemia in People With Type 1 Diabetes

Diabetes type1

Netherlands
Massachusetts General Hospital

Completed

The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

Type1 Diabetes Mellitus

United States
Universidad Loyola Andalucia

Unknown

Evaluation of the Effectiveness of a Program of Emotional Intelligence in Adolescents With Type 1 Diabetes (INTEDI) (INTEDI)

Type1 Diabetes Mellitus

Spain
Jessa Hospital

Completed

Comparison Between Enlite and Flash Glucose Monitoring

Type1 Diabetes Mellitus

Belgium
Eli Lilly and Company

Completed

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

Type1 Diabetes Mellitus

United States
Adocia

Completed

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Type1 Diabetes Mellitus

Germany
AstraZeneca

Completed

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Massachusetts General Hospital

Recruiting

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Diabetes Mellitus | Type 1 Diabetes | Diabetes type1 | Autoimmune Diabetes

United States
Universitair Ziekenhuis Brussel
Juvenile Diabetes Research Foundation; Vrije Universiteit Brussel

Recruiting

Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes

Type1 Diabetes Mellitus

Belgium
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Mechanisms for Restoration of Hypoglycemia Awareness

Type1 Diabetes Mellitus

United States
Samuel Lunenfeld Research Institute, Mount Sinai...
McGill University Health Centre/Research Institute of the McGill University...

Completed

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting (CLASS17)

Type1 Diabetes Mellitus

Canada
HealthCore-NERI
Yale University

Completed

Type 1 Teamwork: A Tool for Parents of Adolescents With Type 1 Diabetes (Type1)

Type1diabetes | Type1 Diabetes Mellitus

United States
Medical University of Warsaw

Unknown

Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

Diabetes type1

Poland
Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom

Clinical Trials on Myotonic Dystrophy, Type 1 (DM1)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations